Terms ending in 2043
Every in-force patent on Pluri Biotech Ltd.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,939,562 | System and Methods for Immune Cells Expansion and Activation in Large Scale In force · High confidence | Pluri Biotech Ltd., | In force | High confidence | |
| US 12,264,308 | System and Methods for Immune Cells Expansion and Activation in Large Scale In force · High confidence | Pluri Biotech Ltd. | In force | High confidence | |
| US 12,291,702 | System and Methods for Immune Cells Expansion and Activation in Large Scale In force · High confidence | Pluri Biotech Ltd. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.